Opendata, web and dolomites

INSCAPE TERMINATED

Imaging Voltage Gated Sodium Channels Using Positron Emission Tomography

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 INSCAPE project word cloud

Explore the words cloud of the INSCAPE project. It provides you a very rough idea of what is the project "INSCAPE" about.

neuronal    nav1    lifes    rare    link    sodium    half    11    fluorine    probe    thirdly    investigation    severe    11c    ing    underlying    imaging    pet    labeled    channels    global    gated    pathogenesis    pharmaceutical    electrical    tool    stability    nav    intensely    hot    central    completely    diseases    society    employed    proteins    tested    first    human    therapies    18f    integral    synthesized    companies    pharmacokinetics    peripheral    block    rodent    fluorescent    communication    assays    small    valuable    scans    positron    isotopes    derivatives    batrachotoxin    revealing    implicated    secondly    radioactive    tr    tomography    blockers    neurons    disclosed    18    metabolic    vivo    neurodegenerative    isoforms    nervous    truncated    therapy    cns    subsequently    primary    emission    transmembrane    btx    candidates    fast    potentially    pain    emitting    purpose    off    carbon    drugs    drug    function    awaited    benefits    signaling    navs    voltage    monitoring    pns   

Project "INSCAPE" data sheet

The following table provides information about the project.

Coordinator
KLINIKUM DER UNIVERSITAET ZU KOELN 

Organization address
address: Kerpener Strasse 62
city: KOELN
postcode: 50937
website: www.uk-koeln.de

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Total cost 239˙860 €
 EC max contribution 239˙860 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2014
 Funding Scheme MSCA-IF-GF
 Starting year 2015
 Duration (year-month-day) from 2015-05-15   to  2018-05-14

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    KLINIKUM DER UNIVERSITAET ZU KOELN DE (KOELN) coordinator 239˙860.00
2    BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY US (STANFORD) partner 0.00

Map

 Project objective

Voltage gated sodium channels (NaVs) are the primary transmembrane proteins underlying fast electrical communication in neurons of the peripheral and central nervous system (PNS and CNS). Being such an integral part of neuronal signaling, they are implicated in a number of severe diseases that have a major impact on human society. However, drugs and established therapies targeting NaVs are rare due to common off-target effects. Therefore, new NaV-blockers will be developed and used for in vivo imaging using positron emission tomography (PET). For this purpose, novel derivatives of the recently disclosed truncated batrachotoxin (tr-BTX), which represent a completely new type of NaV-blockers, will be synthesized and their ability to block different NaV isoforms (NaV1.1 to 1.8) will be tested using fluorescent assays. The most promising candidates will then be labeled using different positron emitting isotopes such as carbon-11 (11C) and fluorine-18 (18F) exploiting different radioactive half-lifes and metabolic stability. The resulting “hot-tr-BTX” will be subsequently employed in small rodent PET-scans revealing their in vivo pharmacokinetics. This novel and unique tool will provide three major immediate benefits. First, hot-tr-BTX might deliver a general imaging probe for nervous activity in the PNS, and potentially the CNS, by monitoring NaV function in vivo. Secondly, this will allow the investigation of various pain conditions and neurodegenerative diseases and link their pathogenesis to NaV-function. Thirdly, the proposed research might deliver not only new NaV-blockers as potential drug candidates, but will also provide a valuable method facilitating the development of long awaited drugs targeting NaVs for pain therapy, a goal that is currently intensely investigated by numerous European and global pharmaceutical companies.

 Publications

year authors and title journal last update
List of publications.
2017 Matthias Schoenberger , Jacob Hooker , Martin Strebl , Al Schroeder , Timothy McKinsey , and Amrut Ambardekar
Imaging cardiac voltage gated sodium channels using the novel F-18 radiotracer radiocaine
published pages: , ISSN: , DOI:
2019-06-13
2017 Matthias Schoenberger, Frederick A. Schroeder, Michael S. Placzek, Randall L. Carter, Bruce R. Rosen, Jacob M. Hooker, Christin Y. Sander
In Vivo [ 18 F]GE-179 Brain Signal Does Not Show NMDA-Specific Modulation with Drug Challenges in Rodents and Nonhuman Primates
published pages: 298-305, ISSN: 1948-7193, DOI: 10.1021/acschemneuro.7b00327
ACS Chemical Neuroscience 9/2 2019-06-13

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "INSCAPE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "INSCAPE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

5G-ACE (2019)

Beyond 5G: 3D Network Modelling for THz-based Ultra-Fast Small Cells

Read More  

TheaTheor (2018)

Theorizing the Production of 'Comedia Nueva': The Process of Play Configuration in Spanish Golden Age Theater

Read More  

LieLowerBounds (2019)

Lower bounds for partial differential operators on compact Lie groups

Read More